Research [ASAP] Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor LikeLiked Date: April 14, 2025 Less than 1 MinRead Views: 27 ACS Chemical Biology DOI: 10.1021/acschembio.5c00097 Source: http://dx.doi.org/10.1021/acschembio.5c00097 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles A comprehensive review of quality measurements of fruits using electronic nose and computer vision Waste Management May 26, 2026 Arth Home / Wright Inspires Built Environment May 25, 2026 pH7 Technologies sees treasure in tailings trash Materials & Chemicals May 25, 2026 Renewables Beat Coal for First Time Since 1919 Energy May 25, 2026 Tesla (TSLA) and BYD Chinese EVs Capture One-Third of South Korea’s Market Share Climate & Resource May 25, 2026 Physics-informed TVAE and probabilistic learning for uncertainty-aware prediction of tensile strength and moisture susceptibility in sustainable asphalt mixtures Research May 25, 2026 Singapore and World Bank Launch New Carbon Markets Programme to Scale High-Integrity Climate Finance Carbon Markets May 25, 2026 8 Predictions for the Future of Fraud Finance & investments May 25, 2026 Clay House / Norenaarquitectos Built Environment May 25, 2026 Homemade Trellis Ideas That Turn Any Garden Into a Beautiful Backyard Escape Food & Agriculture May 25, 2026 Load more
